Legal Challenge Puts Bayer's $7.25B Roundup Settlement in Doubt

Bayer's $7.25B Settlement Faces a Federal Court Challenge

A proposed $7.25 billion settlement covering thousands of Roundup cancer claims is now at risk of delay. An attorney opposed to the deal filed paperwork on Friday to move the case from Missouri state court to federal court. That procedural fight threatens the June 4 opt-out deadline and could push back the final approval hearing scheduled for July 9 in St. Louis Circuit Court.

The move adds a fresh layer of uncertainty for Bayer (BAYN GR), which inherited the Roundup litigation when it acquired Monsanto in 2018. The company already faces a U.S. Supreme Court decision by the end of June in a separate case that could block thousands of state-level failure-to-warn claims. Together, these legal events create a concentrated risk window for Bayer shares over the next four weeks.

Why the Jurisdiction Fight Matters Now

Attorney Ashley Keller, who represents clients opting out of the settlement, argues the process was rushed.